切除性NSCLC的免疫疗法:回答问题还是质疑答案?
Si-Yang Liu1, Wei-Neng Feng2, Yi-Long Wu1
1Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Cancer cell
|May 3, 2024
概括
免疫疗法越来越多地用于可切除的非小细胞肺癌 (NSCLC). 临床试验正在探索最佳的术后治疗模式,包括新辅助和辅助选择,以确定患者的益处.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 基因组学就是基因组学.
背景情况:
- 免疫疗法正在成为可切除非小细胞肺癌 (NSCLC) 术后治疗的关键治疗方式.
- 有相当数量的临床试验正在积极调查扩大的证据基础,以免疫疗法来管理可切除的NSCLC.
- 优化治疗策略,包括新辅助和辅助疗法的时间和组合,对于改善患者的治疗结果至关重要.
研究的目的:
- 用免疫疗法确定可切除非小细胞肺癌 (NSCLC) 的最佳外科手术前治疗模式.
- 确定特定的患者群体,这些患者最有可能从不同的外科手术期间免疫治疗策略中受益.
- 强调在临床试验设计中整合基因组测试和循环瘤DNA (ctDNA) 监测的重要性.
主要方法:
- 审查目前的临床试验评估免疫疗法在外科手术期间设置可切除的NSCLC.
- 分析涉及多学科团队的决策过程.
- 评估组织和血基因组测试在指导治疗选择中的作用.
- 考虑将循环瘤DNA (ctDNA) 监测纳入临床试验设计.
主要成果:
- 切除性NSCLC的外科手术期间免疫治疗的证据基础正在通过众多临床试验迅速扩大.
- 确定最佳治疗顺序 (新辅助剂,辅助剂或组合) 是关键的下一步.
- 基因组测试 (组织和血) 和ctDNA监测是个性化治疗决策和试验设计的重要工具.
结论:
- 在外科手术期间,提供了一个重要的平台,以利用免疫疗法在可切除的NSCLC.
- 为了个性化治疗策略,需要采用结合先进基因组测试的多学科方法.
- 将ctDNA监测有效地整合到临床试验中,对于指导治疗和提高疗效至关重要.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
718
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
相关概念视频
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K